Social Media Ideas for Aridx

Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX)

ARDX closed at $4.00 on August 7, 2026 -- down 17.86% -- after Q2 product revenue of $118.1 million came in below consensus and analysts cut price targets in accord.

argenx SE (ARGX) Forte Biosciences, Inc. - M&A Call - Slideshow

AMG River Road Dividend All Cap Value Fund Q2 2026 Commentary

AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies

ADARx has reinvigorated its ambitions to go public as the AbbVie-backed biotech looks to fund ongoing clinical trials of a range of next-gen small interfering RNA medicines.

ADX Arrow Indicator MT4

The ADX Arrow Indicator MT4 often catches a trader’s attention after a frustrating week of missed trends. A common situation happens when price starts moving strongly, but the entr...

Ardelyx Q2: Strong Demand, But Payer Friction Clouds The Story

Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2026 Earnings Call Transcript

What This $1.1 Million Insider Sale at Accelerant Means for Investors

Executed under a pre-arranged Rule 10b5-1 plan, the transaction reduces Radke's stake by just 0.28%, leaving him with ~28.6 million shares worth $379 million.

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions